REG - Zotefoams PLC - Disclosure of rights attached to equity shares

ZotefoamsAnnouncement

28/04/2020 16:40

RNS Number : 2185L
  
Zotefoams PLC
  
28 April 2020
  
 

Zotefoams plc
(the 'Company')
 
Document regarding rights attached to equity shares
In compliance with Listing Rule 9.2.6ER(1)(b), the Company has submitted to the National Storage Mechanism a copy of its Articles, which set out, amongst other things, the rights attached to its equity shares.
The document is available for inspection at 
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
 
Lydia Harratt
Group Company Secretary
Zotefoams plc
020 8664 1600
 
28 April 2020
 
About Zotefoams plc:       
 
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology.  Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets.  In addition, Zotefoams owns and licenses patented microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT®). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.
 
AZOTE®, ZOTEK® and T-FIT® are registered trademarks of Zotefoams plc
www.zotefoams.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
CIRIPMATMTJTBRM